Literature DB >> 15135067

Transactivation of erbB2 by short and long isoforms of leptin receptors.

Avital Eisenberg1, Eva Biener, Madia Charlier, R V Krishnan, Jean Djiane, Brian Herman, Arieh Gertler.   

Abstract

We generated kinase-positive and kinase-negative erbB2 tagged with YFP and the long form of leptin receptor (LEPRb) tagged with CFP. Both were as active as their untagged analogs. Both short and long isoforms of leptin receptor phosphorylated and thereby activated erbB2 upon leptin binding and enhanced MAPK activity. Our results unveil a novel route by which leptin may provoke erbB2's phosphorylation and thus enhance its oncogenic potential independently of HER family ligands or its overexpression. Using FRET technology in living cells, we found no evidence of complex formation between erbB2 and prolactin or leptin receptors, indicating that the transactivation occurs through an indirect interaction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135067     DOI: 10.1016/j.febslet.2004.03.089

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Metabolic imaging in multiple time scales.

Authors:  V Krishnan Ramanujan
Journal:  Methods       Date:  2013-09-04       Impact factor: 3.608

2.  Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.

Authors:  Shanchun Guo; Ruben R Gonzalez-Perez
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

3.  Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis.

Authors:  Yan-Jie Xu; Yong-Feng Shao; Xia Zhao; Yi-Ting Geng; Kai Wang; Yong-Mei Yin
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-17       Impact factor: 4.553

Review 4.  Role of Notch and its oncogenic signaling crosstalk in breast cancer.

Authors:  Shanchun Guo; Mingli Liu; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2010-12-28

Review 5.  Leptin and breast cancer: an overview.

Authors:  Mehmet Artac; Kadri Altundag
Journal:  Med Oncol       Date:  2011-08-30       Impact factor: 3.064

6.  Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation.

Authors:  Ruben R Gonzalez-Perez; Yanbo Xu; Shanchun Guo; Amber Watters; Weiqiang Zhou; Samuel J Leibovich
Journal:  Cell Signal       Date:  2010-05-11       Impact factor: 4.315

7.  ErbB4 regulates the timely progression of late fetal lung development.

Authors:  Washa Liu; Erkhembulgan Purevdorj; Katja Zscheppang; Dietlinde von Mayersbach; Jan Behrens; Maria-Jantje Brinkhaus; Heber C Nielsen; Andreas Schmiedl; Christiane E L Dammann
Journal:  Biochim Biophys Acta       Date:  2010-03-17

Review 8.  The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.

Authors:  A Dittrich; H Gautrey; D Browell; A Tyson-Capper
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-12-28       Impact factor: 2.673

9.  Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.

Authors:  Thomas E Reznik; Yingying Sang; Yongxian Ma; Roger Abounader; Eliot M Rosen; Shuli Xia; John Laterra
Journal:  Mol Cancer Res       Date:  2008-01       Impact factor: 5.852

Review 10.  Role of leptin and its receptors in the pathogenesis of thyroid cancer.

Authors:  Shahab Uddin; Azhar R Hussain; Abdul K Siraj; Omar S Khan; Prashant P Bavi; Khawla S Al-Kuraya
Journal:  Int J Clin Exp Pathol       Date:  2011-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.